Why Did I Lose Vision? A Qualitative Study of Patient Perceptions of the Causes of Age-Related Macular Disease

REFERENCES

• Evans J, Rooney C, Ashwood F, Dattani N, Wormald R P. Blindness and partial sight in England and Wales: April 1990–March 1991. Health Trends. 1996; 28: 5–12
   Google Scholar
• Friedman D S, O'Colmain B J, Munoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004; 122: 564–572
   PubMed Web of Science ®Google Scholar
• Livingston P M, McCarty C A, Taylor H R. Knowledge, attitudes, and self care practices associated with age related eye disease in Australia. Br J Ophthalmol. 1998; 82: 780–785
   PubMed Web of Science ®Google Scholar
• Lau J TF, Lee V, Fan D, Lau M, Michon J. Knowledge about cataract, glaucoma, and age related macular degeneration in the Hong Kong Chinese population. Br J Ophthalmol. 2002; 86: 1080–1084
   PubMed Web of Science ®Google Scholar
• Rosenthal B, Thompson B. Awareness of age-related macular degeneration in adults: the results of a large-scale international survey. Optometry. 2003; 74: 16–24
   PubMedGoogle Scholar
• Silvestri G, Johnston P B, Hughes A E. Is genetic predisposition an important risk factor in age-related macular degeneration?. Eye. 1994; 8: 564–568
   PubMed Web of Science ®Google Scholar
• Evans J R, Fletcher A E, Wormald R PL. 28 000 cases of age-related macular degeneration causing visual loss in people aged 75 years and above in the United Kingdom may be attributable to smoking. Br J Ophthalmol. 2005; 89: 550–553
   PubMed Web of Science ®Google Scholar
• Khan J C, Thurlby D A, Shahid H, et al. Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br J Ophthalmol. 2006; 90: 75–80
   PubMed Web of Science ®Google Scholar
• Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology. 2001; 108: 697–704
   PubMed Web of Science ®Google Scholar
• Age-related Eye Disease Study Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001; 119: 1417–1436
   PubMedGoogle Scholar
• Taylor H R, Munoz B, West S, Bressler N M, Bressler S B, Rosenthal B P. Visible light and risk of age-related macular degeneration. Trans Am Ophthalmol Soc. 1990; 88: 163–173
   PubMedGoogle Scholar
• West S K, Rosenthal F S, Bressler N M, et al. Exposure to sunlight and other risk factors for age-related macular degeneration. Arch Ophthalmol. 1989; 107: 875–879
   PubMed Web of Science ®Google Scholar
• Khan J C, Shahid H, Thurlby D A, et al. Age related macular degeneration and sun exposure, iris colour, and skin sensitivity to sunlight. Br J Ophthalmol. 2006; 90: 29–32
   PubMed Web of Science ®Google Scholar
• Pope C, Ziebland S, Mays N. Qualitative research in health care: Analysing qualitative data. BMJ 2000; 320: 114–116
   PubMed Web of Science ®Google Scholar
• The Guardian. Warning of smoking link to blindness, 7 September 2005
   Google Scholar
• BBC. Smokers' blindness risk ‘doubled’, BBC News 6 September 2005
   Google Scholar
• Pollack A, Marcovich A, Bukelman A, Oliver M. Age-related macular degeneration after extracapsular cataract extraction with intraocular lens implantation. Ophthalmology. 1996; 103: 1546–1554
   PubMed Web of Science ®Google Scholar
• Klein R, Klein B E, Jensen S C, Cruickshanks K J. The relationship of ocular factors to the incidence and progression of age-related maculopathy. Arch Ophthalmol. 1998; 116: 506–513
   PubMedGoogle Scholar
• Freeman E E, Munoz B, West S K, Tielsch J M, Schein O D. Is there an association between cataract surgery and age-related macular degeneration? Data from three population-based studies. Am J Ophthalmol. 2003; 135: 849–856
   PubMed Web of Science ®Google Scholar
• Macular Photocoagulation Study Group. Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration: the influence of initial lesion size and initial visual acuity. Arch Ophthalmol. 1994; 112: 480–488
   PubMedGoogle Scholar
• Blumenkranz M S, Bressler N M, Bressler S B, et al. Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials—TAP Report no. 5. Arch Ophthalmol. 2002; 120: 1307–1314
   PubMed Web of Science ®Google Scholar
• Helman C G. New research methods in medical anthropology. Culture, Health and Illness. Arnold, London 2000; 265–271
   Google Scholar
• Crossland M D, Silver J. Thirty years in an urban low vision clinic: changes in prescribing habits of low vision practitioners. Optom Vis Sci. 2005; 82: 617–622
   PubMed Web of Science ®Google Scholar
• Elliott D B, Trukolo-Ilic M, Strong J G, Pace R, Plotkin A, Bevers P. Demographic characteristics of the vision disabled elderly. Invest Ophthalmol Vis Sci. 1997; 38: 2566–2575
   PubMed Web of Science ®Google Scholar
• Wolffsohn J S, Cochrane A L. The changing face of the visually impaired: the Kooyong low vision clinic's past, present, and future. Optom Vis Sci. 1999; 76: 747–754
   PubMed Web of Science ®Google Scholar
• Ohman A. Qualitative methodology for rehabilitation research. J Rehabil Med. 2005; 37: 273–280
   PubMed Web of Science ®Google Scholar